NO20061334L - Indanyl-piperanzinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem - Google Patents
Indanyl-piperanzinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende demInfo
- Publication number
- NO20061334L NO20061334L NO20061334A NO20061334A NO20061334L NO 20061334 L NO20061334 L NO 20061334L NO 20061334 A NO20061334 A NO 20061334A NO 20061334 A NO20061334 A NO 20061334A NO 20061334 L NO20061334 L NO 20061334L
- Authority
- NO
- Norway
- Prior art keywords
- hydrogen atom
- piperanzine
- indanyl
- compounds
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/36—Radicals substituted by singly-bound nitrogen atoms
- C07D213/40—Acylated substituent nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0503071A FR2883876B1 (fr) | 2005-03-30 | 2005-03-30 | Derives d'indanyl-piperazines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20061334L true NO20061334L (no) | 2006-10-02 |
Family
ID=35079249
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20061334A NO20061334L (no) | 2005-03-30 | 2006-03-23 | Indanyl-piperanzinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem |
Country Status (37)
Country | Link |
---|---|
US (1) | US7442692B2 (el) |
EP (1) | EP1707564B1 (el) |
JP (1) | JP4503549B2 (el) |
KR (1) | KR100766664B1 (el) |
CN (1) | CN100467458C (el) |
AP (1) | AP2007004169A0 (el) |
AR (1) | AR054747A1 (el) |
AT (1) | ATE372992T1 (el) |
AU (1) | AU2006201326A1 (el) |
BR (1) | BRPI0602132A (el) |
CA (1) | CA2541066C (el) |
CR (1) | CR9391A (el) |
CY (1) | CY1107028T1 (el) |
DE (1) | DE602006000102T2 (el) |
DK (1) | DK1707564T3 (el) |
EA (1) | EA010051B1 (el) |
ES (1) | ES2293630T3 (el) |
FR (1) | FR2883876B1 (el) |
GE (1) | GEP20084544B (el) |
GT (1) | GT200700084A (el) |
HK (1) | HK1096386A1 (el) |
HR (1) | HRP20070498T3 (el) |
IL (1) | IL186062A (el) |
MA (1) | MA28211A1 (el) |
MX (1) | MXPA06003552A (el) |
MY (1) | MY140325A (el) |
NO (1) | NO20061334L (el) |
NZ (1) | NZ546186A (el) |
PL (1) | PL1707564T3 (el) |
PT (1) | PT1707564E (el) |
RS (1) | RS50527B (el) |
SG (1) | SG126113A1 (el) |
SI (1) | SI1707564T1 (el) |
TN (1) | TNSN07357A1 (el) |
UA (1) | UA87989C2 (el) |
WO (1) | WO2006103342A2 (el) |
ZA (1) | ZA200602631B (el) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8071778B2 (en) * | 2006-07-27 | 2011-12-06 | Bristol-Myers Squibb Company | Substituted heterocyclic ethers and their use in CNS disorders |
US20090018163A1 (en) * | 2007-07-11 | 2009-01-15 | Bristol-Myers Squibb Company | Substituted Heterocyclic Ethers and Their Use in CNS Disorders |
US8026257B2 (en) * | 2007-07-11 | 2011-09-27 | Bristol-Myers Squibb Company | Substituted heterocyclic ethers and their use in CNS disorders |
US7632861B2 (en) * | 2007-11-13 | 2009-12-15 | Bristol-Myers Squibb Company | Substituted heterocyclic ethers and their use in CNS disorders |
EP3628666A1 (en) | 2018-09-25 | 2020-04-01 | Antabio SAS | Indane derivatives for use in the treatment of bacterial infection |
WO2020064175A1 (en) | 2018-09-25 | 2020-04-02 | Antabio Sas | Indane derivatives for use in the treatment of bacterial infection |
US20220112169A1 (en) | 2018-09-25 | 2022-04-14 | Antabio Sas | Indane derivatives for use in the treatment of bacterial infection |
EP3628672A1 (en) | 2018-09-25 | 2020-04-01 | Antabio SAS | Indane derivatives for use in the treatment of bacterial infection |
WO2021191240A1 (en) | 2020-03-24 | 2021-09-30 | Antabio Sas | Combination therapy |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1335591C (en) * | 1988-05-23 | 1995-05-16 | James Arthur Nixon | Ring-substituted 2-amino-1,2,3,4-tetrahydronaphthalenes |
DK286990D0 (da) * | 1990-12-04 | 1990-12-04 | Lundbeck & Co As H | Indanderivater |
CA2175395A1 (en) * | 1995-06-02 | 1996-12-03 | Ronald J. Mattson | Melatonergic indanyl piperazines or homopiperazines |
FR2769312B1 (fr) * | 1997-10-03 | 1999-12-03 | Adir | Nouveaux composes de l'indanol, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
FR2827284B1 (fr) * | 2001-07-16 | 2003-10-31 | Servier Lab | Nouveaux derives de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
US20050250814A1 (en) * | 2002-10-30 | 2005-11-10 | Cangyou Zhou | Piperidinyl-alpha-aminoamide modulators of chemokine receptor activity |
-
2005
- 2005-03-30 FR FR0503071A patent/FR2883876B1/fr not_active Expired - Fee Related
-
2006
- 2006-03-16 MA MA28880A patent/MA28211A1/fr unknown
- 2006-03-23 NO NO20061334A patent/NO20061334L/no not_active Application Discontinuation
- 2006-03-28 SG SG200602026A patent/SG126113A1/en unknown
- 2006-03-28 GE GEAP20069324A patent/GEP20084544B/en unknown
- 2006-03-28 NZ NZ546186A patent/NZ546186A/en not_active IP Right Cessation
- 2006-03-29 PT PT06290494T patent/PT1707564E/pt unknown
- 2006-03-29 DE DE602006000102T patent/DE602006000102T2/de active Active
- 2006-03-29 PL PL06290494T patent/PL1707564T3/pl unknown
- 2006-03-29 DK DK06290494T patent/DK1707564T3/da active
- 2006-03-29 EP EP06290494A patent/EP1707564B1/fr active Active
- 2006-03-29 AT AT06290494T patent/ATE372992T1/de active
- 2006-03-29 US US11/391,916 patent/US7442692B2/en not_active Expired - Fee Related
- 2006-03-29 SI SI200630005T patent/SI1707564T1/sl unknown
- 2006-03-29 AP AP2007004169A patent/AP2007004169A0/xx unknown
- 2006-03-29 MY MYPI20061369A patent/MY140325A/en unknown
- 2006-03-29 WO PCT/FR2006/000673 patent/WO2006103342A2/fr not_active Application Discontinuation
- 2006-03-29 EA EA200600487A patent/EA010051B1/ru not_active IP Right Cessation
- 2006-03-29 UA UAA200603429A patent/UA87989C2/ru unknown
- 2006-03-29 ES ES06290494T patent/ES2293630T3/es active Active
- 2006-03-29 RS RSP-2007/0478A patent/RS50527B/sr unknown
- 2006-03-30 BR BRPI0602132-8A patent/BRPI0602132A/pt not_active IP Right Cessation
- 2006-03-30 CA CA2541066A patent/CA2541066C/fr not_active Expired - Fee Related
- 2006-03-30 AR ARP060101238A patent/AR054747A1/es not_active Application Discontinuation
- 2006-03-30 ZA ZA200602631A patent/ZA200602631B/xx unknown
- 2006-03-30 CN CNB2006100669637A patent/CN100467458C/zh not_active Expired - Fee Related
- 2006-03-30 AU AU2006201326A patent/AU2006201326A1/en not_active Abandoned
- 2006-03-30 KR KR1020060029085A patent/KR100766664B1/ko not_active IP Right Cessation
- 2006-03-30 MX MXPA06003552A patent/MXPA06003552A/es active IP Right Grant
- 2006-03-30 JP JP2006093025A patent/JP4503549B2/ja not_active Expired - Fee Related
-
2007
- 2007-02-01 HK HK07101184.7A patent/HK1096386A1/xx not_active IP Right Cessation
- 2007-09-18 TN TNP2007000357A patent/TNSN07357A1/en unknown
- 2007-09-19 IL IL186062A patent/IL186062A/en not_active IP Right Cessation
- 2007-09-24 CR CR9391A patent/CR9391A/es not_active Application Discontinuation
- 2007-09-28 GT GT200700084A patent/GT200700084A/es unknown
- 2007-10-25 HR HR20070498T patent/HRP20070498T3/xx unknown
- 2007-11-28 CY CY20071101540T patent/CY1107028T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20061334L (no) | Indanyl-piperanzinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
TW200732284A (en) | Amine compound and pharmaceutical use thereof | |
TW200612920A (en) | Novel imidazolidine derivatives | |
ECSP10010006A (es) | Derivado de oxopirazina y herbicida | |
EA017861B9 (ru) | Способ получения 4-оксохинолинового соединения | |
AU2008255733A8 (en) | Novel 1,2,3,4-tetrahydroquinoxaline derivative which has, as substituent, phenyl group having sulfonic acid ester structure or sulfonic acid amide structure introduced therein and has glucocorticoid receptor-binding activity | |
TW200517387A (en) | Compounds exhibiting thrombopoietin receptor agonism | |
NO20082436L (no) | Forbindelser med medisinske effekter grunnet interaksjonen med glukokortikoidreseptor | |
NO20061604L (no) | Piperazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
CY1111653T1 (el) | Φαρμακευτικη συνθεση περιεχουσα παραγωγα 2,3-διυδρο-6-νιτροϊμιδαζο [2,1-β] οξαζολιου | |
EA201000666A1 (ru) | Производные 5-замещенных индол-3-карбоновой кислоты, обладающие противовирусной активностью, способ их получения и применение | |
ATE286050T1 (de) | Heterozyclische oder benzol derivate von liponsäure, deren herstellung und deren verwendung als heilmittel | |
NO20050391L (no) | Nye fluorinerte benzotiadiazinforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem | |
SE1069132T5 (sv) | Bicykliska derivate av amino-pyrazinoner, foerfarande foer framstaellning och farmaceutiska kompositioner innehallande dem | |
EA200970120A1 (ru) | Новые производные 5-тиоксилопиранозы | |
EP2020302B8 (en) | Optical recording material and cyanine compound | |
PT1572198E (pt) | Novos compostos farmaceuticos com actividade de receptor alfa2. | |
NO20022891L (no) | Nye cykliske <alfa>-amino-<gamma>-hydroksyamidforbindelser, fremgangsmåte ved deres fremstilling og farmasöytiske sammensetningerinneholdende dem | |
MY142362A (en) | Pharmaceutical composition for promoting angiogenesis | |
TH76337A (th) | อนุพันธ์อิมิแดโซลิดีนชนิดใหม่ | |
TH96569A (th) | สารประกอบที่อนุพัทธ์มาจากพิริมิดีนที่เป็นไคเนส Aurora อินฮิบิเตอร์ | |
CU20070216A7 (es) | Derivados de indanil-piperazinas, su procedimiento de preparación y las composiciones farmacéuticas que lo contienen | |
TH117350B (th) | ไพโรคาทีคอลที่ต้านแบตทีเรียและวิธีการที่เกี่ยวข้อง | |
TH105529A (th) | สารผสมทางเภสัชกรรม | |
TH105529B (th) | สารผสมทางเภสัชกรรม |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |